Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cumberland Pharmaceuticals (CPIX) Shares Repurchased (2016 - 2025)

Cumberland Pharmaceuticals' Shares Repurchased history spans 16 years, with the latest figure at $10439.0 for Q3 2025.

  • For Q3 2025, Shares Repurchased fell 89.44% year-over-year to $10439.0; the TTM value through Dec 2025 reached $263478.0, down 54.5%, while the annual FY2025 figure was $263478.0, 54.5% down from the prior year.
  • Shares Repurchased for Q3 2025 was $10439.0 at Cumberland Pharmaceuticals, up from $7171.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $580130.0 in Q1 2022 and bottomed at $7171.0 in Q2 2025.
  • The 5-year median for Shares Repurchased is $198912.0 (2022), against an average of $216845.9.
  • The largest annual shift saw Shares Repurchased skyrocketed 91.59% in 2022 before it plummeted 94.66% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $361192.0 in 2021, then plummeted by 47.49% to $189659.0 in 2022, then decreased by 1.34% to $187117.0 in 2023, then tumbled by 47.42% to $98383.0 in 2024, then crashed by 89.39% to $10439.0 in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Shares Repurchased are $10439.0 (Q3 2025), $7171.0 (Q2 2025), and $245868.0 (Q1 2025).